English | Español
Nicholas Gueguen | Jul 20, 2017

Bristol-Myers Squibb, Incyte begin registrational trials of Opdivo-epacadostat combo therapy for treating two types of cancer
Nicholas Gueguen | Jul 19, 2017

Limited insurance plans limit cancer care options, study says
John Breslin | Jul 17, 2017

Surgeon general nominee welcomed by medical community
Robert Hadley | Jul 15, 2017

FDA approves use of cooling cap to stall hair loss from chemotherapy
John Breslin | Jul 13, 2017

Insurance companies begin to roll out proposed rate increases

Michael McGrady | Jul 12, 2017

Biosimilars policy should weigh patient safety, drug savings

Robert Hadley | Jul 12, 2017

Pfizer’s immunotherapy drug OKd for leukemia treatment in Europe
John Breslin | Jul 10, 2017

Rising cost of chronic mental health conditions could hit $3.5 trillion by 2030

Trending
Patient Daily | Sep 3, 2025

Top healthcare marketing experts to present at AOCOO-HNS 2025 virtual mid-year symposium, led by Greg Caesar of Medfluence Advisors
+ Pharmaceuticals
Patient Daily | Sep 4, 2025

PhRMA CEO on 340B abuse: ‘Big hospitals are abusing the 340B program to markup medicine prices’
+ Pharmaceuticals
Patient Daily | Sep 2, 2025

Fmr. Gov. Dean on 340B: ‘There's no actual requirement for hospitals to pass along the savings’
+ Pharmaceuticals
Patient Daily | Aug 29, 2025

Deputy VP of Public Affairs of PhRMA on 340B: ‘Over 80% of all rural hospital beds were actually in urban hospitals’